Skip to content
Screener

NeoGenomics NEO Total Current Assets

Total Current Assets at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
$312.8M+8.9%
Labcorp Holdings logo
Labcorp HoldingsLH
$3.81B-6.7%
Quest Diagnostics logo
Quest DiagnosticsDGX
$2.84B+29.4%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
$43.57M+34.3%
Personalis, Inc. logo
Personalis, Inc.PSNL
$258.2M+25.1%
Guardant Health logo
Guardant HealthGH
$1.37B+47.5%

Other financials

Income statement

See full
Revenue$201.7M+11.2%
Gross profit$91.9M+18.9%
Operating income-$9.8M+79.5%
Net income$2.2M+105%
EPS (diluted)$0.02+106%

Balance sheet

See full
Cash & equivalents$145.5M-5.9%
Total debt$448.4M+534%
Total equity$785.7M-8.0%
Total assets$1.4B-3.0%

Cash flow

See full
Operating cash flow$20.0M-1.8%
CapEx$8.2M+30.0%
Free cash flow-$13.1M+56.0%

Valuation

See full
Market cap$2.13B+183%
Enterprise value$2.43B+264%
P/S2.8×+1.7×

Profitability

See full
Gross margin43.9%0.0pp
Operating margin-8.9%-2.8pp
Net margin-6.8%-2.4pp
FCF margin-4.9%

Returns & leverage

See full
Return on equity-6.3%-2.0pp
Debt / equity0.6×+0.5×
Current ratio3.6×-0.3×

Where this comes from

Reported directly by NeoGenomics in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The source filing: NeoGenomics’s 10-Q, filed July 28, 2026.

Filed
Jul 28, 2026, 4:09 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001077183-26-000059
Line item(unaudited)June 30, 2026December 31, 2025
Inventories27,13728,566
Prepaid assets23,59021,443
Other current assets9,8077,417
Total current assets381,478376,286
Property and equipment (net of accumulated depreciation of $223,479 and $209,057, respectively)80,93884,834
Operating lease right-of-use assets78,60678,444
Financing lease right-of-use assets6,65354
Intangible assets, net271,262286,528

Item 1. Financial Statements (unaudited)

FAQ

What is NeoGenomics's total current assets?
NeoGenomics (NEO) reported total current assets of $381.48M in Q2 2026.
How has NeoGenomics's total current assets changed year-over-year?
NeoGenomics's total current assets decreased by 2.8% year-over-year, from $392.55M to $381.48M.
What is the long-term trend for NeoGenomics's total current assets?
Over 5 years (2020 to 2025), NeoGenomics's total current assets has grown at a -3.5% compound annual growth rate (CAGR), from $448.73M to $376.29M.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.

Ask your AI about NeoGenomics's total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude